Skip to main content

Autism: Brainwaves 'show risk from age of six months'

It may be possible to detect autism at a much earlier age than previously thought, according to an international team of researchers.
A study published in Current Biology identified differences in infants' brainwaves from as early as six months.
Behavioural symptoms of autism typically develop between a child's first and second birthdays.
Autism charities said identifying the disorder at an earlier stage could help with treatment.
It is thought that one in every 100 children has an autism spectrum disorder in the UK. It affects more boys than girls. While there is no "cure", education and behavioural programmes can help.
One of the researchers, Prof Mark Johnson from Birkbeck College, University of London, told the BBC: "The prevailing view is that if we are able to intervene before the onset of full symptoms, such as a training programme, at least in some cases we can maybe alleviate full symptoms."
His team looked for the earliest signs of autism in 104 children aged between six and 10 months. Half were known to be at risk of the disorder because they had on older sibling who had been diagnosed with autism. The rest were low risk.
Older children with autism can show a lack of eye contact, so the babies were shown pictures of people's faces that switched between looking at or away from the baby.
Sensors attached to the scalp looked for differences in brain activity.
In low-risk babies, or high-risk babies that did not develop autism, there was a large difference in the brainwaves when looking at each type of image.
There was a much smaller difference in the brainwaves of babies who developed autism.'Very effective'
Prof Johnson said: "It is important to note it is not a 100% predictor. We had babies who flagged up warning signs who did not develop autism."
There were also babies who did develop autism who had low-risk brainwaves. The test would need to be more accurate before it was used routinely.
Prof Tony Charman, Centre for Research in Autism and Education at the Institute of Education, said: "Differences in the use of eye gaze to regulate social interaction are already a well-recognised early feature in many children with autism from the second year of life.
"Future studies will be required to determine whether measurements of brain function such as those used in our study might one day play a role in helping to identify children at an even earlier age."
 
Christine Swabey from the charity Autistica said: "The hope is that this important research will lead to improved identification and access to services for future generations.
"Ultimately, the earlier we can identify autism and provide early intervention, the better the outcomes will be."
Dr Georgina Gomez-de-la-Cuesta from the National Autistic Society said: "Further research to investigate these differences will eventually lead to earlier recognition of the condition.
"Early intervention is very effective in supporting those with autism, so recognition in infancy can only be beneficial in helping individuals with autism reach their full potential.
"However, this important research is still in its early stages, and larger studies looking at several early markers of autism will be necessary before a robust clinical diagnosis could be possible at such a young age."

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

FDA Decision Delayed for Truvada in HIV PrEP

June 11, 2012 — The US Food and Drug Administration (FDA) has delayed its decision on allowing the use of tenofovir disoproxil fumarate/emtricitabine ( Truvada , Gilead) as preexposure prophylaxis (PrEP) so that the proposed risk evaluation and mitigation strategy (REMS) can be reviewed. In early May, the FDA's Antiviral Drugs Advisory Committee  strongly backed  approval of the first-ever drug for the prevention of sexually acquired HIV-1 infection. However, concerns by the panel at the time included that people may neglect condom use if they feel they are protected by PrEP. Panelists were also concerned that uninfected people taking PrEP who become infected with HIV may not switch to a 3-drug regimen as recommended. According to the company, the FDA has postponed the target date to September 14 so it can review Gilead's REMS plan to help ensure that patients will not misuse the drug. The committee's recommendation for supplemental approval of tenofovir/emtricit...
Post a Comment
Read more

Antidepressants Linked to Higher Diabetes Risk in Kids

Pediatric patients who use antidepressants may have an elevated risk for type 2 diabetes, the authors of a new study report. In a retrospective cohort study of more than 119,000 youths 5 to 20 years of age, the risk for incident type 2 diabetes was nearly twice as high among current users of certain types of antidepressants as among former users, Mehmet Burcu, PhD, and colleagues report in an article  published online October 16 in  JAMA Pediatrics . The risk intensified with increasing duration of use, greater cumulative doses, and higher daily doses of these antidepressants. The findings point to a growing need for closer monitoring of these products, including greater balancing of risks and benefits, in the pediatric population, the authors caution. They undertook the study because, despite growing evidence of an association between antidepressant use and an increased risk for type 2 diabetes in adults, similar research in pediatric patients was scarce. "To our know...
Post a Comment
Read more